147 related articles for article (PubMed ID: 16014264)
1. [Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication].
Svendsen KB; Jensen TS; Bach FW
Ugeskr Laeger; 2005 Jun; 167(25-31):2772-4. PubMed ID: 16014264
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Rog DJ; Nurmikko TJ; Friede T; Young CA
Neurology; 2005 Sep; 65(6):812-9. PubMed ID: 16186518
[TBL] [Abstract][Full Text] [Related]
4. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Svendsen KB; Jensen TS; Bach FW
BMJ; 2004 Jul; 329(7460):253. PubMed ID: 15258006
[TBL] [Abstract][Full Text] [Related]
5. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.
Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN
J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560
[TBL] [Abstract][Full Text] [Related]
7. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
[TBL] [Abstract][Full Text] [Related]
8. Are oral cannabinoids safe and effective in refractory neuropathic pain?
Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
10. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
11. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
[TBL] [Abstract][Full Text] [Related]
12. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
13. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
Roberts JD; Gennings C; Shih M
Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U
JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710
[TBL] [Abstract][Full Text] [Related]
16. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
[TBL] [Abstract][Full Text] [Related]
17. Onset of analgesia of a paracetamol tablet containing sodium bicarbonate: A double-blind, placebo-controlled study in adult patients with acute sore throat.
Burnett I; Schachtel B; Sanner K; Bey M; Grattan T; Littlejohn S
Clin Ther; 2006 Sep; 28(9):1273-8. PubMed ID: 17062300
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
Pickering G; Loriot MA; Libert F; Eschalier A; Beaune P; Dubray C
Clin Pharmacol Ther; 2006 Apr; 79(4):371-8. PubMed ID: 16580905
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use.
Schoedel KA; Chen N; Hilliard A; White L; Stott C; Russo E; Wright S; Guy G; Romach MK; Sellers EM
Hum Psychopharmacol; 2011 Apr; 26(3):224-36. PubMed ID: 21671456
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Klooker TK; Leliefeld KE; Van Den Wijngaard RM; Boeckxstaens GE
Neurogastroenterol Motil; 2011 Jan; 23(1):30-5, e2. PubMed ID: 20718944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
